Aelis Farma (XPAR:AELIS) Net Margin %: 0.00% (As of Dec. 2025)


XPAR:AELIS Aelis Farma SA XPAR:AELIS
33 GF Score
Price €1.04
GF Value €0.98
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Aelis Farma Net Margin %?

Aelis Farma XPAR:AELIS -0.95% 33 Net Margin % is 0.00% as of Dec. 2025. GuruFocus rates XPAR:AELIS with a GF Score™ of 33/100 and a GF Value™ of €0.98 (Fairly Valued). The stock has 4 warning signs investors should review. Among 941 Biotechnology companies, Aelis Farma ranks worse than 106269.82% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Aelis Farma's Net Income for the six months ended in Dec. 2025 was €-2.11 Mil. Aelis Farma's Revenue for the six months ended in Dec. 2025 was €0.00 Mil. Therefore, Aelis Farma's net margin for the quarter that ended in Dec. 2025 was 0.00%.

The historical rank and industry rank for Aelis Farma's Net Margin % or its related term are showing as below:


XPAR:AELIS's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.3
* Ranked among companies with meaningful Net Margin % only.

Aelis Farma  (XPAR:AELIS) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Aelis Farma Net Margin % Related Terms

Aelis Farma Net Margin % Historical Data

* Premium members only.

The historical data trend for Aelis Farma's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aelis Farma Net Margin % Chart

Aelis Farma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only 6.33 -375.11 -56.09 -278.42 0.00

Aelis Farma Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -64.76 -160.53 -868.39 0.00 0.00

XPAR:AELIS vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Aelis Farma's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aelis Farma Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aelis Farma's Net Margin % distribution charts can be found below:

* The bar in red indicates where Aelis Farma's Net Margin % falls into.


XPAR:AELIS
33GF Score
Aelis Farma SA XPAR:AELIS
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aelis Farma Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Aelis Farma's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-6.434/0
= %

Aelis Farma's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-2.111/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Aelis Farma (XPAR:AELIS) has a Net Margin % of 0.00% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Aelis Farma and its competitors. According to the industry distribution chart, Aelis Farma ranks #999999 out of 941 companies in the Biotechnology industry.
Is Aelis Farma's Net Margin % too high?
Aelis Farma's current Net Margin % is 0.00%. Based on the distribution chart, Aelis Farma ranks #999999 out of 941 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Aelis Farma has a GF Score™ of 33/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Aelis Farma's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Aelis Farma ranks #999999 out of 941 companies for Net Margin %. This places Aelis Farma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Aelis Farma and its competitors. Aelis Farma's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aelis Farma stock overvalued right now?
Based on GuruFocus' analysis, Aelis Farma (XPAR:AELIS) is currently considered Fairly Valued. The stock's GF Value™ is €0.98, compared to a current price of €1.04 — trading 6.1% above its estimated fair value. The current Net Margin % is 0.00%. Aelis Farma's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Aelis Farma (XPAR:AELIS), the current Net Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aelis Farma (XPAR:AELIS) Overvalued in 2026?

Based on GuruFocus' analysis, Aelis Farma stock appears to be overvalued. The current stock price of €1.04 is trading 6.1% above its estimated GF Value™ of €0.98. GuruFocus considers Aelis Farma to be Fairly Valued.

Key valuation signals for XPAR:AELIS:

  • Net Margin %: 0.00%
  • GF Value™: €0.98 vs. price of €1.04 (6.1% above fair value)
  • GF Score™: 33/100 with 4 warning signs

No single metric tells the full story. See the XPAR:AELIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aelis Farma Business Description

Other Exchanges 69O:Germany
Address 2 rue Robert Escarpit, IECB, Pessac, Bordeaux, FRA, 33607
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases. The Company operates in only one business segment: the research and development of pharmaceutical products.
33GF Score

Get the complete analysis for XPAR:AELIS

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.04
Price
€0.98
GF Value